11 | less than a week out from launch! any predictions | Bent2Break | 07/25/2017 2:01:54 PM |
10 | nice moves +29% doesn't take much volume to get | Bent2Break | 07/11/2017 12:31:26 PM |
9 | HRRN Financials 07/16/2014 19:16:15 HE-5 | Emylers | 07/16/2014 8:16:10 PM |
8 | HRRN 0.0002 Stock Charts $HRRN 1 Month Chart | chartguy89 | 03/07/2014 7:08:50 PM |
7 | HRRN Stock Charts Last: UNCH Wednesday, February | chartguy89 | 02/26/2014 9:58:49 PM |
6 | MY PLAYS LAST 5-7+ DAYS...HRRN IS GOING INTO DAY | stockfalcon | 02/19/2013 6:46:10 AM |
5 | HRRN .0009 im telling you all we are going to | stockfalcon | 02/19/2013 6:45:32 AM |
4 | Many groups joining in on tuesday...alerted at | stockfalcon | 02/18/2013 6:27:37 PM |
3 | The reason why it moved from .0002 to .0009 so | stockfalcon | 02/18/2013 6:25:58 PM |
2 | Check the chart back in oct last year....took | stockfalcon | 02/18/2013 6:25:19 PM |
1 | HRRN .0009 Maxed AS/OS play...my favorite | stockfalcon | 02/18/2013 6:24:01 PM |
Recent Articles
- ServiceTitan Reveals Impressive Growth in Financial Performance
- Madrigal Pharmaceuticals Equity Awards for New Employees
- Sportsman’s Warehouse Upgrades Financial Prospects with Q2 Gains
- Deadline Approaches for Charter Communications Shareholders
- ServiceTitan and Roto-Rooter Forge Partnership for Growth
- Revolutionizing Road Safety: The All-New Auto Air Pump
- Lifecore Biomedical Showcases Expertise at Industry Event
- MediaAlpha's Strategic $32.9 Million Stock Repurchase Plan
- Legal Action Against Snap Inc. Attracts Investor Attention
- Capricor Therapeutics Faces Class Action Lawsuit: What Investors Need to Know
- Top Health Care Stocks with Impressive Dividend Returns
- Stretch U Celebrates 15 Years of Transformative Stretch Therapy
- Understanding KLA Inc.'s Earnings Performance and Stock Position
- Agora Enhances User Interaction with OpenAI's Realtime API
- Market Insights: Recent Trends in BellRing Brands Options
- Scholastic Corporation Sets Earnings Call for Fiscal 2026
- Market Trends in Options Trading for Joby Aviation Revealed
- Amgen's Participation in Major Healthcare Conference Announced
- Exploring Enphase Energy's Recent Options Activity Surge
- Goldman Sachs Economist Jan Hatzius Receives Prestigious Award
- Toledo Zoo Marks 125 Years with International Conservation Focus
- Brixmor Property Group Announces Senior Notes Offering Details
- Rocketlane Gears Up for PropelX 2025 Event in the UK Market
- Docusign Reports Strong Performance Despite Market Challenges
- Hatch to Drive Pre-Feasibility for Ramaco's Brook Mine Project
- Trinity Capital Inc. Expands Credit Facility to $690 Million
- International Tower Hill Mines Announces Metallurgy Breakthrough
- Zimmer Biomet to Present Innovative Foot and Ankle Solutions
- Lineage, Inc. Faces Securities Lawsuit: Important Update for Investors
- Altimmune, Inc. Faces Securities Lawsuit: Key Insights
- Celebrate National Chicken Month with El Pollo Loco's Exciting Offers!
- Lockheed Martin Faces Legal Actions Over Securities Fraud Allegations
- Tevogen Bio Explores Potential of TVGN 930 in Hematologic Cancers
- Novo Nordisk A/S Faces Class Action – Key Updates for Investors
- Biohaven shareholders may take action as class period ends soon
- Join the Class Action Against C3.ai for Investor Rights
- Salesforce's AI Efforts in 2025: A Mixed Bag of Results
- Unicycive Therapeutics Faces Suit Over Alleged Misstatements
- Investors Encouraged to Join iRobot Corporation Class Action
- Identifying Financial Stocks to Consider Selling Now
- Graybar Expands STAR Centers for Enhanced Logistics Solutions
- BiotechBeauty®: Innovating Clean Makeup Through Science
- Whitley Penn Welcomes James McNamara as New Tax Partner
- Credilab's Robust Growth: A Leap to US$35 Million Loan Book
- Exploring Gold's Potential Surge Amid Political Pressures
- Investing in Oversold Stocks: Key Players to Watch Now
- Experience the Thrill of the 2027 Mediterranean Solar Eclipse
- Exploring WisdomAI's Innovative Proactive Agents for Analytics
- Strategic Recapitalization Analysis for Green Infrastructure Partners
- Syndax Pharmaceuticals: Unlocking Potential in Leukemia Treatments